Annual Working Capital
$109.09 M
-$13.99 M-11.37%
31 December 2023
Summary:
Heron Therapeutics annual working capital is currently $109.09 million, with the most recent change of -$13.99 million (-11.37%) on 31 December 2023. During the last 3 years, it has fallen by -$102.60 million (-48.47%). HRTX annual working capital is now -71.47% below its all-time high of $382.36 million, reached on 31 December 2019.HRTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$109.64 M
-$1.21 M-1.09%
30 September 2024
Summary:
Heron Therapeutics quarterly working capital is currently $109.64 million, with the most recent change of -$1.21 million (-1.09%) on 30 September 2024. Over the past year, it has dropped by -$4.59 million (-4.02%). HRTX quarterly working capital is now -74.14% below its all-time high of $423.96 million, reached on 30 June 2018.HRTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.4% | -4.0% |
| 3 y3 years | -48.5% | -54.8% |
| 5 y5 years | -69.3% | -59.0% |
HRTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -48.5% | at low | -54.8% | +39.6% |
| 5 y | 5 years | -71.5% | at low | -71.3% | +39.6% |
| alltime | all time | -71.5% | >+9999.0% | -74.1% | >+9999.0% |
Heron Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $109.64 M(-1.1%) |
| June 2024 | - | $110.85 M(+0.3%) |
| Mar 2024 | - | $110.53 M(+1.3%) |
| Dec 2023 | $109.09 M(-11.4%) | $109.09 M(-4.5%) |
| Sept 2023 | - | $114.23 M(+45.4%) |
| June 2023 | - | $78.56 M(-21.6%) |
| Mar 2023 | - | $100.26 M(-18.5%) |
| Dec 2022 | $123.08 M(-32.9%) | $123.08 M(-5.3%) |
| Sept 2022 | - | $129.93 M(+53.4%) |
| June 2022 | - | $84.71 M(-34.6%) |
| Mar 2022 | - | $129.59 M(-29.3%) |
| Dec 2021 | $183.37 M(-13.4%) | $183.37 M(-24.5%) |
| Sept 2021 | - | $242.76 M(-14.7%) |
| June 2021 | - | $284.68 M(+66.1%) |
| Mar 2021 | - | $171.37 M(-19.0%) |
| Dec 2020 | $211.69 M(-44.6%) | $211.69 M(-16.5%) |
| Sept 2020 | - | $253.42 M(-15.6%) |
| June 2020 | - | $300.24 M(-12.1%) |
| Mar 2020 | - | $341.68 M(-10.6%) |
| Dec 2019 | $382.36 M(+7.6%) | $382.36 M(+43.0%) |
| Sept 2019 | - | $267.41 M(-6.4%) |
| June 2019 | - | $285.78 M(-9.0%) |
| Mar 2019 | - | $313.95 M(-11.6%) |
| Dec 2018 | $355.23 M(+184.4%) | $355.23 M(-10.3%) |
| Sept 2018 | - | $395.97 M(-6.6%) |
| June 2018 | - | $423.96 M(+396.5%) |
| Mar 2018 | - | $85.39 M(-31.6%) |
| Dec 2017 | $124.89 M(+433.5%) | $124.89 M(+110.1%) |
| Sept 2017 | - | $59.45 M(-32.5%) |
| June 2017 | - | $88.06 M(-39.8%) |
| Mar 2017 | - | $146.22 M(+524.6%) |
| Dec 2016 | $23.41 M(-79.6%) | $23.41 M(-62.9%) |
| Sept 2016 | - | $63.05 M(+18.4%) |
| June 2016 | - | $53.24 M(-40.2%) |
| Mar 2016 | - | $89.03 M(-22.6%) |
| Dec 2015 | $115.02 M(+91.3%) | $115.02 M(-17.0%) |
| Sept 2015 | - | $138.54 M(-11.7%) |
| June 2015 | - | $156.83 M(+249.5%) |
| Mar 2015 | - | $44.88 M(-25.3%) |
| Dec 2014 | $60.11 M(-8.8%) | $60.11 M(-22.9%) |
| Sept 2014 | - | $77.97 M(-17.7%) |
| June 2014 | - | $94.74 M(+81.0%) |
| Mar 2014 | - | $52.35 M(-20.6%) |
| Dec 2013 | $65.93 M(+32.0%) | $65.93 M(+269.1%) |
| Sept 2013 | - | $17.86 M(-30.3%) |
| June 2013 | - | $25.62 M(-33.6%) |
| Mar 2013 | - | $38.55 M(-22.8%) |
| Dec 2012 | $49.94 M(+243.3%) | $49.94 M(-11.1%) |
| Sept 2012 | - | $56.16 M(+468.2%) |
| June 2012 | - | $9.88 M(-4.9%) |
| Mar 2012 | - | $10.39 M(-28.6%) |
| Dec 2011 | $14.55 M(+1445.9%) | $14.55 M(-22.5%) |
| Sept 2011 | - | $18.78 M(+0.8%) |
| June 2011 | - | $18.63 M(<-9900.0%) |
| Mar 2011 | - | -$182.00 K(-119.3%) |
| Dec 2010 | $941.00 K(-85.4%) | $941.00 K(-58.4%) |
| Sept 2010 | - | $2.26 M(-39.7%) |
| June 2010 | - | $3.75 M(-39.9%) |
| Mar 2010 | - | $6.24 M(-2.9%) |
| Dec 2009 | $6.43 M(-15.8%) | $6.43 M(-7161.5%) |
| Sept 2009 | - | -$91.00 K(-105.8%) |
| June 2009 | - | $1.57 M(-68.6%) |
| Mar 2009 | - | $4.98 M(-34.7%) |
| Dec 2008 | $7.63 M(-74.2%) | $7.63 M(-31.9%) |
| Sept 2008 | - | $11.20 M(-34.3%) |
| June 2008 | - | $17.05 M(-25.5%) |
| Mar 2008 | - | $22.88 M(-22.7%) |
| Dec 2007 | $29.59 M(+146.3%) | $29.59 M(-20.5%) |
| Sept 2007 | - | $37.21 M(-12.0%) |
| June 2007 | - | $42.28 M(+574.0%) |
| Mar 2007 | - | $6.27 M(-47.8%) |
| Dec 2006 | $12.01 M | $12.01 M(-27.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $16.47 M(-17.9%) |
| June 2006 | - | $20.05 M(-17.8%) |
| Mar 2006 | - | $24.39 M(+399.7%) |
| Dec 2005 | $4.88 M(-61.4%) | $4.88 M(-33.4%) |
| Sept 2005 | - | $7.33 M(-19.9%) |
| June 2005 | - | $9.15 M(-20.9%) |
| Mar 2005 | - | $11.57 M(-8.5%) |
| Dec 2004 | $12.64 M(+34.9%) | $12.64 M(-14.2%) |
| Sept 2004 | - | $14.73 M(-11.1%) |
| June 2004 | - | $16.57 M(+133.0%) |
| Mar 2004 | - | $7.11 M(-24.1%) |
| Dec 2003 | $9.37 M(-33.0%) | $9.37 M(-12.7%) |
| Sept 2003 | - | $10.73 M(-8.9%) |
| June 2003 | - | $11.77 M(-13.8%) |
| Mar 2003 | - | $13.65 M(-2.4%) |
| Dec 2002 | $13.99 M(-22.6%) | $13.99 M(-3.4%) |
| Sept 2002 | - | $14.47 M(-6.9%) |
| June 2002 | - | $15.54 M(-9.2%) |
| Mar 2002 | - | $17.11 M(-5.3%) |
| Dec 2001 | $18.07 M(-10.0%) | $18.07 M(-8.8%) |
| Sept 2001 | - | $19.81 M(+10.0%) |
| June 2001 | - | $18.01 M(-6.6%) |
| Mar 2001 | - | $19.28 M(-4.0%) |
| Dec 2000 | $20.09 M(+52.3%) | $20.09 M(-6.6%) |
| Sept 2000 | - | $21.51 M(+71.0%) |
| June 2000 | - | $12.58 M(+35.4%) |
| Mar 2000 | - | $9.29 M(-29.6%) |
| Dec 1999 | $13.19 M(+180.7%) | $13.19 M(+51.6%) |
| Sept 1999 | - | $8.70 M(-7.4%) |
| June 1999 | - | $9.40 M(+1.1%) |
| Mar 1999 | - | $9.30 M(+97.9%) |
| Dec 1998 | $4.70 M(-23.0%) | $4.70 M(+6.8%) |
| Sept 1998 | - | $4.40 M(+76.0%) |
| June 1998 | - | $2.50 M(-3.8%) |
| Mar 1998 | - | $2.60 M(-57.4%) |
| Dec 1997 | $6.10 M(+60.5%) | $6.10 M(+32.6%) |
| Sept 1997 | - | $4.60 M(+12.2%) |
| June 1997 | - | $4.10 M(+2.5%) |
| Mar 1997 | - | $4.00 M(+5.3%) |
| Dec 1996 | $3.80 M(-24.0%) | $3.80 M(-43.3%) |
| Sept 1996 | - | $6.70 M(-18.3%) |
| June 1996 | - | $8.20 M(+9.3%) |
| Mar 1996 | - | $7.50 M(+50.0%) |
| Dec 1995 | $5.00 M(-12.3%) | $5.00 M(-35.9%) |
| Sept 1995 | - | $7.80 M(+59.2%) |
| June 1995 | - | $4.90 M(-24.6%) |
| Mar 1995 | - | $6.50 M(+14.0%) |
| Dec 1994 | $5.70 M(+23.9%) | $5.70 M(-16.2%) |
| Sept 1994 | - | $6.80 M(-15.0%) |
| June 1994 | - | $8.00 M(+77.8%) |
| Mar 1994 | - | $4.50 M(-2.2%) |
| Dec 1993 | $4.60 M(-68.7%) | $4.60 M(-37.8%) |
| Sept 1993 | - | $7.40 M(-26.0%) |
| June 1993 | - | $10.00 M(-22.5%) |
| Mar 1993 | - | $12.90 M(-12.2%) |
| Dec 1992 | $14.70 M(+539.1%) | $14.70 M(-14.5%) |
| Sept 1992 | - | $17.20 M(+18.6%) |
| June 1992 | - | $14.50 M(+22.9%) |
| Mar 1992 | - | $11.80 M(+413.0%) |
| Dec 1991 | $2.30 M(-41.0%) | $2.30 M(+9.5%) |
| Sept 1991 | - | $2.10 M(-25.0%) |
| June 1991 | - | $2.80 M(-3.4%) |
| Mar 1991 | - | $2.90 M(-25.6%) |
| Dec 1990 | $3.90 M(-51.9%) | $3.90 M(+39.3%) |
| Sept 1990 | - | $2.80 M(-30.0%) |
| June 1990 | - | $4.00 M(-45.9%) |
| Mar 1990 | - | $7.40 M(-8.6%) |
| Dec 1989 | $8.10 M(-30.8%) | $8.10 M(-12.0%) |
| Sept 1989 | - | $9.20 M(-9.8%) |
| June 1989 | - | $10.20 M(-12.8%) |
| Dec 1988 | $11.70 M(-25.9%) | $11.70 M(-25.9%) |
| Dec 1987 | $15.80 M | $15.80 M |
FAQ
- What is Heron Therapeutics annual working capital?
- What is the all time high annual working capital for Heron Therapeutics?
- What is Heron Therapeutics annual working capital year-on-year change?
- What is Heron Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Heron Therapeutics?
- What is Heron Therapeutics quarterly working capital year-on-year change?
What is Heron Therapeutics annual working capital?
The current annual working capital of HRTX is $109.09 M
What is the all time high annual working capital for Heron Therapeutics?
Heron Therapeutics all-time high annual working capital is $382.36 M
What is Heron Therapeutics annual working capital year-on-year change?
Over the past year, HRTX annual working capital has changed by -$13.99 M (-11.37%)
What is Heron Therapeutics quarterly working capital?
The current quarterly working capital of HRTX is $109.64 M
What is the all time high quarterly working capital for Heron Therapeutics?
Heron Therapeutics all-time high quarterly working capital is $423.96 M
What is Heron Therapeutics quarterly working capital year-on-year change?
Over the past year, HRTX quarterly working capital has changed by -$4.59 M (-4.02%)